Follow
Ioannis Vizirianakis
Ioannis Vizirianakis
Associate Professor of Molecular Pharmacology and Pharmacogenomics
Verified email at pharm.auth.gr - Homepage
Title
Cited by
Cited by
Year
Erythropoiesis: model systems, molecular regulators, and developmental programs
AS Tsiftsoglou, IS Vizirianakis, J Strouboulis
IUBMB life 61 (8), 800-830, 2009
2432009
Mechanisms involved in the induced differentiation of leukemia cells
AS Tsiftsoglou, IS Pappas, IS Vizirianakis
Pharmacology & therapeutics 100 (3), 257-290, 2003
2142003
Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes
IS Vizirianakis
Nanomedicine: Nanotechnology, Biology and Medicine 7 (1), 11-17, 2011
1062011
Lipid-like self-assembling peptide nanovesicles for drug delivery
DG Fatouros, DA Lamprou, AJ Urquhart, SN Yannopoulos, IS Vizirianakis, ...
ACS applied materials & interfaces 6 (11), 8184-8189, 2014
942014
Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriers
M Filippousi, S Turner, K Leus, PI Siafaka, ED Tseligka, M Vandichel, ...
International Journal of Pharmaceutics 509 (1-2), 208-218, 2016
892016
Controlled release of 5-fluorouracil from microporous zeolites
M Spanakis, N Bouropoulos, D Theodoropoulos, L Sygellou, S Ewart, ...
Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 197-205, 2014
892014
Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine
IS Vizirianakis
European Journal of Pharmaceutical Sciences 15 (3), 243-250, 2002
642002
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation
E Sayed, C Karavasili, K Ruparelia, R Haj-Ahmad, G Charalambopoulou, ...
Journal of Controlled Release 278, 142-155, 2018
572018
Synergistic antitumor potency of a self-assembling peptide hydrogel for the local co-delivery of doxorubicin and curcumin in the treatment of head and neck cancer
C Karavasili, DA Andreadis, OL Katsamenis, E Panteris, P Anastasiadou, ...
Molecular Pharmaceutics 16 (6), 2326-2341, 2019
532019
Modified chitosan coated mesoporous strontium hydroxyapatite nanorods as drug carriers
M Filippousi, PI Siafaka, EP Amanatiadou, SG Nanaki, M Nerantzaki, ...
Journal of Materials Chemistry B 3 (29), 5991-6000, 2015
462015
Development of a nanoporous and multilayer drug-delivery platform for medical implants
V Karagkiozaki, E Vavoulidis, PG Karagiannidis, M Gioti, DG Fatouros, ...
International journal of nanomedicine 7, 5327, 2012
432012
Synthesis, molecular structure determination, and antitumor activity of platinum (II) and palladium (II) complexes of 2-substituted benzimidazole.
S Mylonas, A Valavanidis, K Dimitropoulos, M Polissiou, AS Tsiftsoglou, ...
Journal of inorganic biochemistry 34 (4), 265-275, 1988
421988
Development of new drug delivery system based on ordered mesoporous carbons: characterisation and cytocompatibility studies
C Karavasili, EP Amanatiadou, L Sygellou, DK Giasafaki, TA Steriotis, ...
Journal of Materials Chemistry B 1 (25), 3167-3174, 2013
412013
Fabrication of mucoadhesive buccal films for local administration of ketoprofen and lidocaine hydrochloride by combining fused deposition modeling and inkjet printing
GK Eleftheriadis, PK Monou, N Bouropoulos, J Boetker, J Rantanen, ...
Journal of Pharmaceutical Sciences 109 (9), 2757-2766, 2020
392020
Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells
IS Vizirianakis, YQ Chen, SS Kantak, AS Tsiftsoglou, RH Kramer
International journal of oncology 21 (1), 135-144, 2002
392002
Chemotherapeutic delivery from a self-assembling peptide nanofiber hydrogel for the management of glioblastoma
C Karavasili, E Panteris, IS Vizirianakis, S Koutsopoulos, DG Fatouros
Pharmaceutical Research 35 (8), 1-13, 2018
362018
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives
IS Vizirianakis, M Chatzopoulou, ID Bonovolias, I Nicolaou, ...
Journal of medicinal chemistry 53 (19), 6779-6810, 2010
352010
Desmoglein-3/γ-catenin and E-cadherin/-catenin differential expression in oral leukoplakia and squamous cell carcinoma
M Kyrodimou, D Andreadis, A Drougou, EP Amanatiadou, L Angelis, ...
Clinical oral investigations 18 (1), 199-210, 2014
342014
Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements.
IS Vizirianakis, DG Fatouros
Advanced drug delivery reviews 64 (13), 1359-1362, 2012
342012
The developmental program of murine erythroleukemia cells
AS Tsiftsoglou, IS Pappas, IS Vizirianakis
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 13…, 2003
342003
The system can't perform the operation now. Try again later.
Articles 1–20